The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.08BEUR
1.20B · vs all stocks (USD)
Updated Oct 25, 2026
Revenue (TTM)
2.32BEUR
2.57B · vs all stocks (USD)
Updated Oct 25, 2026
Profit Margin
-17.51%
vs Medical Instruments & Supplies peers
Updated Oct 25, 2026
Beta
0.4480x
vs all stocks
Updated Oct 25, 2026
52-Week Change
6.60%
vs all stocks
Updated Oct 25, 2026
Market Capitalization
1.08BEUR
1.20B · vs all stocks (USD)
Updated Oct 25, 2026
Enterprise Value
3.27BEUR
3.62B · vs all stocks (USD)
Updated Oct 25, 2026
Forward P/E
10.30x
vs Medical Instruments & Supplies peers
Updated Oct 25, 2026
Price to Sales (TTM)
0.4672x
vs Medical Instruments & Supplies peers
Updated Oct 25, 2026
Price to Book (MRQ)
1.13x
vs Medical Instruments & Supplies peers
Updated Oct 25, 2026
Enterprise to Revenue
1.41x
vs Medical Instruments & Supplies peers
Updated Oct 25, 2026
Enterprise to EBITDA
10.11x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 9.84×.Updated Oct 25, 2026
Gross Margin
0.28%
vs Medical Instruments & Supplies peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 20.96%.Updated Oct 25, 2026
Profit Margin
-17.51%
vs Medical Instruments & Supplies peers
Updated Oct 25, 2026
Operating Margin
-10.96%
vs Medical Instruments & Supplies peers
Updated Oct 25, 2026
Return on Assets (TTM)
0.52%
vs Medical Instruments & Supplies peers
Updated Oct 25, 2026
Return on Equity (TTM)
-32.35%
vs Medical Instruments & Supplies peers
Updated Oct 25, 2026
Revenue (TTM)
2.32BEUR
2.57B · vs all stocks (USD)
Updated Oct 25, 2026
Revenue per Share (TTM)
67.09EURUpdated Oct 25, 2026
Quarterly Revenue Growth
-0.80%
vs Medical Instruments & Supplies peers
Updated Oct 25, 2026
Gross Profit (TTM)
485.57MEUR
538.28M · vs all stocks (USD)
Updated Oct 25, 2026
EBITDA (TTM)
331.88MEUR
367.91M · vs all stocks (USD)
Updated Oct 25, 2026
Net Income (TTM)
-409.18MEUR
-453.59M · vs all stocks (USD)
Updated Oct 25, 2026
Quarterly Earnings Growth (YoY)
28.28%
vs Medical Instruments & Supplies peers
Updated Oct 25, 2026
Operating Cash Flow (TTM)
261.60MEUR
290.00M · vs all stocks (USD)
Updated Oct 25, 2026
Levered Free Cash Flow (TTM)
-175.75MEUR
-194.82M · vs all stocks (USD)
Updated Oct 25, 2026
5-Year Average Dividend Yield
0.43%
vs all stocks
Updated Oct 25, 2026
Payout Ratio
3.85%
vs Medical Instruments & Supplies peers
Updated Oct 25, 2026
Minority Interest (Equity)
25.86MEURFY2025 · Nov 30, 2025
Revenue
2.32BEURFY2025 · Nov 30, 2025
Cost of Goods Sold
1.90BEURFY2025 · Nov 30, 2025
Gross Profit
425.25MEURFY2025 · Nov 30, 2025
Operating Income
-70.79MEUR
-78.47M · vs all stocks (USD)
FY2025 · Nov 30, 2025
Pre-tax Income
-330.13MEURFY2025 · Nov 30, 2025
Income Tax Expense
-11.41MEURFY2025 · Nov 30, 2025
Net Income
-318.72MEURFY2025 · Nov 30, 2025
EBIT
-232.36MEURFY2025 · Nov 30, 2025
EBITDA (Income Statement)
373.75MEURFY2025 · Nov 30, 2025
Research & Development
80.98MEURFY2025 · Nov 30, 2025
Selling, General & Administrative
381.14MEURFY2025 · Nov 30, 2025
Other Operating Expenses
3.20MEURFY2025 · Nov 30, 2025
Non-operating Interest Income
3.67MEURFY2025 · Nov 30, 2025
Non-operating Interest Expense
97.77MEURFY2025 · Nov 30, 2025
EPS (Basic)
-9.27EURFY2025 · Nov 30, 2025
EPS (Diluted)
-9.27EURFY2025 · Nov 30, 2025
Basic Shares Outstanding
34.54MSharesFY2025 · Nov 30, 2025
Diluted Shares Outstanding
34.54MSharesFY2025 · Nov 30, 2025
Net Income from Continuing Operations
-318.72MEURFY2025 · Nov 30, 2025
Minority Interests (P&L)
-1.59MEURFY2025 · Nov 30, 2025
Preferred Stock Dividends
0.00EURFY2025 · Nov 30, 2025
Operating Cash Flow
-247.23MEURFY2025 · Nov 30, 2025
Cash & Cash Equivalents (End of Period)
173.09MEURFY2025 · Nov 30, 2025
Starting Profit (CF Statement)
-318.72MEURFY2025 · Nov 30, 2025
Other Non-cash Items
105.34MEURFY2025 · Nov 30, 2025
Change in Accounts Receivable (CF)
-38.47MEURFY2025 · Nov 30, 2025
Change in Other Assets/Liabilities
4.62MEURFY2025 · Nov 30, 2025
Net Acquisitions
-366.70MEURFY2025 · Nov 30, 2025
Other Investing Activity
13.26MEURFY2025 · Nov 30, 2025
Net Investing Cash Flow
-353.44MEURFY2025 · Nov 30, 2025
Long-term Debt Issuance
1.64BEURFY2025 · Nov 30, 2025
Long-term Debt Payments
-1.15BEURFY2025 · Nov 30, 2025
Other Financing Charges
-1.15MEURFY2025 · Nov 30, 2025
Net Financing Cash Flow
484.83MEURFY2025 · Nov 30, 2025
Shares Outstanding
34.54MSharesUpdated Oct 25, 2026
Float Shares
32.05MSharesUpdated Oct 25, 2026
% Held by Insiders
11.42%
vs all stocks
Updated Oct 25, 2026
% Held by Institutions
72.60%
vs all stocks
Updated Oct 25, 2026
Total Cash (MRQ)
167.61MEUR
185.81M · vs all stocks (USD)
Updated Oct 25, 2026
Total Cash per Share (MRQ)
4.85EURUpdated Oct 25, 2026
Total Debt (MRQ)
2.33BEUR
2.58B · vs all stocks (USD)
Updated Oct 25, 2026
Total Debt to Equity (MRQ)
2.37x
vs Medical Instruments & Supplies peers
Updated Oct 25, 2026
Current Ratio (MRQ)
1.07x
vs Medical Instruments & Supplies peers
Updated Oct 25, 2026
Book Value per Share (MRQ)
27.69EURUpdated Oct 25, 2026
Total Assets
4.49BEUR
4.98B · vs all stocks (USD)
FY2025 · Nov 30, 2025
Total Current Assets
1.10BEURFY2025 · Nov 30, 2025
Total Liabilities
3.39BEURFY2025 · Nov 30, 2025
Total Non-current Assets
3.39BEURFY2025 · Nov 30, 2025
Total Non-current Liabilities
2.03BEURFY2025 · Nov 30, 2025
Total Current Liabilities
1.36BEURFY2025 · Nov 30, 2025
Cash & Cash Equivalents
176.21MEURFY2025 · Nov 30, 2025
Other Short-term Investments
14.72MEURFY2025 · Nov 30, 2025
Accounts Receivable
331.52MEURFY2025 · Nov 30, 2025
Inventory
446.51MEURFY2025 · Nov 30, 2025
Accounts Payable
426.97MEURFY2025 · Nov 30, 2025
Short-term Debt
573.43MEURFY2025 · Nov 30, 2025
Other Current Liabilities
103.11MEURFY2025 · Nov 30, 2025
Long-term Debt
1.60BEURFY2025 · Nov 30, 2025
Other Non-current Liabilities
724.00KEURFY2025 · Nov 30, 2025
Common Stock (Book)
34.54MEURFY2025 · Nov 30, 2025
Retained Earnings
907.05MEURFY2025 · Nov 30, 2025
Total Shareholders' Equity
1.11BEUR
1.23B · vs all stocks (USD)
FY2025 · Nov 30, 2025
52-Week Low
14.83EURUpdated Oct 25, 2026
52-Week High
33.28EURUpdated Oct 25, 2026
52-Week Change
6.60%
vs all stocks
Updated Oct 25, 2026
Beta
0.4480x
vs all stocks
Updated Oct 25, 2026
50-Day MA
28.18EURUpdated Oct 25, 2026
200-Day MA
25.00EURUpdated Oct 25, 2026
Avg 10-Day Volume
178.58KSharesUpdated Oct 25, 2026
Avg 30-Day Volume
133.76KSharesUpdated Oct 25, 2026
Diluted EPS (TTM)
-11.86EURUpdated Oct 25, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 0.3%, lower than 95% of its Medical Instruments & Supplies peers (median 49.2%)Significant